PDF(Pubmed)
Abstract：
To examine the influence of Body Mass Index (BMI) on laparoscopic gastrectomy (LG) short-term and long-term outcomes for gastric cancer. A retrospective analysis was conducted on gastric cancer patients undergoing LG at the Third Hospital of Nanchang City from January 2013 to January 2022. Based on WHO BMI standards, patients were categorized into normal weight, overweight, and obese groups. Factors such as operative time, intraoperative blood loss, postoperative complications, and overall survival were assessed. Across different BMI groups, it was found that an increase in BMI was associated with longer operative times (average times: 206.22 min for normal weight, 231.32 min for overweight, and 246.78 min for obese), with no significant differences noted in intraoperative blood loss, postoperative complications, or long-term survival among the groups. The impact of BMI on long-term survival following LG for gastric cancer was found to be insignificant, with no notable differences in survival outcome between different BMI groups. Although higher BMI is associated with increased operative time in LG for gastric cancer, it does not significantly affect intraoperative blood loss, postoperative complications, recovery, or long-term survival. LG is a feasible treatment choice for obese patients with gastric cancer.
摘要：
探讨体重指数(BMI)对腹腔镜胃癌根治术(LG)近期及远期疗效的影响。回顾性分析2013年1月至2022年1月南昌市第三医院接受LG治疗的胃癌患者。根据WHOBMI标准,患者被归类为正常体重，超重,和肥胖群体。手术时间等因素，术中失血,术后并发症,并评估总生存率.在不同的BMI组中，研究发现，BMI的增加与更长的手术时间有关（平均时间：正常体重为206.22分钟，231.32分钟超重，肥胖者为246.78分钟)，术中失血量无显著差异，术后并发症,或群体之间的长期生存。发现BMI对LG治疗胃癌后长期生存率的影响是微不足道的，不同BMI组间生存结局无显著差异。尽管较高的BMI与LG胃癌手术时间增加有关，它不会显着影响术中失血，术后并发症,recovery,或长期生存。LG是肥胖胃癌患者的可行治疗选择。
